Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
spacer
Blue curve MMWR spacer
spacer
spacer

The content, links, and pdfs are no longer maintained and might be outdated.

  • The content on this page is being archived for historic and reference purposes only.
  • For current, updated information see the MMWR website.

Using Self-Testing to Augment Syndromic Surveillance --- United Kingdom, December 2003--January 2004

Duncan L. Cooper,1 G. Smith,1 P. Loveridge,1 F. Chinemana,2 E. Gerard,2 C. Joseph,3 M. Baker,4 D. Mant,5 J. Watson,3 R. Griffiths,5 M. Zambon6
1
Health Protection Agency, West Midlands, England; 2NHS Direct, London, England; 3Communicable Disease Surveillance Centre, Health Protection Agency, London, England; 4Royal College of General Practitioners, London, England; 5University of Oxford, England; 6Health Protection Agency, London, England

Corresponding author: Duncan Cooper, Health Protection Agency, Regional Surveillance Unit, Floor 2, Lincoln House, Heartlands Hospital, Bordesley Green East, Birmingham, B9 5SS, United Kingdom. Telephone: 44-121-773-7077; Fax: 44-121-773-1407; E-mail: duncan.cooper@hpa.org.uk.

Disclosure of relationship: The contributors of this report have disclosed that they have no financial interest, relationship, affiliation, or other association with any organization that might represent a conflict of interest. In addition, this report does not contain any discussion of unlabeled use of commercial products or products for investigational use. Abstract

Introduction: Effective community surveillance is needed for the rapid identification of outbreaks of serious illness. In the United Kingdom, surveillance of calls to NHS Direct, a national telephone health helpline, are used as a method of rapid outbreak detection. A limitation of this syndromic surveillance approach is the lack of laboratory confirmation of diagnosis after surveillance signals have been generated.

Objective: This report presents a pilot study to investigate the feasibility of virologic sampling conducted by NHS Direct callers.

Methods: During December 2003--January 2004, NHS Direct nurses in two regions of England were asked to recruit NHS Direct callers aged >12 years who had reported cold or influenza symptoms (i.e., "cold/flu" callers). Persons who agreed to participate in the study were mailed a specimen kit. Callers were asked to take a swab from each nostril and return the swabs by mail to the United Kingdom national influenza reference laboratory. Swabs were tested by multiplex polymerase chain reaction (PCR) for influenza viruses and, if identified as positive, were cultured for viable virus isolation.

Results: During the study period, 686 cold/flu callers were eligible for the study. Although 67 of these were recruited for the study, determining how many cold/flu callers were asked to participate but refused was impossible. Of the 67 specimen kits sent, 36 (54%) were returned to the laboratory. The mean time between the call to NHS Direct and laboratory analysis of the specimen was 7.5 days. This period was shorter for positive samples (mean time: 6.12 days) than negative samples (mean time: 7.9 days), although the difference was not significant (p = 0.13). Eight specimens (22%) were positive on PCR for influenza virus. Five were antigenically characterized as Fuijian/411/2002-like influenza A H3N2. Higher positivity rates might have been achieved if the sampling study had begun earlier in the year before the peak of the influenza season.

Conclusion: This study demonstrates the possibility of community-based clinical surveillance that does not require sampling by a health-care worker. This methodology will allow novel approaches to be developed to integrate syndromic surveillance with virologic sampling. Therefore, the rapid follow up of syndromic surveillance signals might provide confirmation of a specific common infection or provide evidence of a potentially more sinister cause.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.


References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

Date last reviewed: 8/5/2005

HOME  |  ABOUT MMWR  |  MMWR SEARCH  |  DOWNLOADS  |  RSSCONTACT
POLICY  |  DISCLAIMER  |  ACCESSIBILITY

Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A

USA.GovDHHS

Department of Health
and Human Services